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Abstract
Background: The nature of symptoms in the prodromal period of first episode psychosis (FEP) remains unclear.
The objective was to determine the patterns of symptoms recorded in primary care in the 5 years before FEP
diagnosis.
Methods: The study was set within 568 practices contributing to a UK primary care health record database (Clinical
Practice Research Datalink). Patients aged 16–45 years with a first coded record of FEP, and no antipsychotic
prescription more than 1 year prior to FEP diagnosis (n = 3045) was age, gender, and practice matched to controls
without FEP (n = 12,180). Fifty-five symptoms recorded in primary care in the previous 5 years, categorised into 8
groups (mood-related, ‘neurotic’, behavioural change, volition change, cognitive change, perceptual problem,
substance misuse, physical symptoms), were compared between cases and controls. Common patterns of
symptoms prior to FEP diagnosis were identified using latent class analysis.
Results: Median age at diagnosis was 30 years, 63% were male. Non-affective psychosis (67%) was the most common
diagnosis. Mood-related, ‘neurotic’, and physical symptoms were frequently recorded (> 30% of patients) before
diagnosis, and behavioural change, volition change, and substance misuse were also common (> 10%). Prevalence of
all symptom groups was higher in FEP patients than in controls (adjusted odds ratios 1.33–112). Median time from the
first recorded symptom to FEP diagnosis was 2–2.5 years except for perceptual problem (70 days). The optimal latent
class model applied to FEP patients determined three distinct patient clusters: ‘no or minimal symptom cluster’ (49%)
had no or few symptoms recorded; ‘affective symptom cluster’ (40%) mainly had mood-related and ‘neurotic’
symptoms; and ‘multiple symptom cluster’ (11%) consulted for three or more symptom groups before diagnosis. The
multiple symptom cluster was more likely to have drug-induced psychosis, female, obese, and have a higher morbidity
burden. Affective and multiple symptom clusters showed a good discriminative ability (C-statistic 0.766; sensitivity
51.2% and specificity 86.7%) for FEP, and many patients in these clusters had consulted for their symptoms several
years before FEP diagnosis.
Conclusions: Distinctive patterns of prodromal symptoms may help alert general practitioners to those developing
psychosis, facilitating earlier identification and referral to specialist care, thereby avoiding potentially detrimental
treatment delay.
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Background
There is often a substantial gap between the first presen-
tation of symptoms and subsequent diagnosis of a first
episode psychosis (FEP) leading to a delay in treatment
and worse outcomes [1]. The average duration of un-
treated psychosis (DUP), the period between the first on-
set of psychotic symptoms and treatment, has been
reported to be over a year [2–4]. Several independent
meta-analyses have provided evidence for the association
between long DUP and poor outcome. Marshall et al. in-
cluded 26 studies involving prospective cohorts with
over 4000 participants. This meta-analysis revealed sig-
nificant associations between long DUP and poor out-
comes in symptomatic and functional domains at 6 and
12months after diagnosis, which were independent of
co-morbidity [5]. Perkins et al. included 44 studies in-
volving 5491 participants and demonstrated that longer
DUP was associated with less response to antipsychotic
medication [1]. Penttilä et al. included 33 studies with a
mean follow-up of 8.1 years and concluded that long
DUP was associated with poor general symptomatic out-
come, more severe positive and negative symptoms,
lesser likelihood of remission, and poor social function-
ing and global outcome in the long term [4]. Reducing
DUP has become the primary aim of modern psychiatric
services for patients with a FEP.
Initiatives to shorten DUP, however, have largely been
unsuccessful [6]. This is partly due to the fact that the
nature of symptoms in the prodromal period remains
unclear. In a systematic review, Anderson et al. explored
the nature of the pathway to care for patients experien-
cing a FEP. Almost all studies in this review explored
the sex, socio-economic, or ethnic determinants of the
pathways to care. The authors commented that the na-
ture of the pathway to care, which includes understand-
ing the symptoms and presentations in the period before
the diagnosis of FEP, is crucial in understanding the
delay in contact with services [7]. Some studies have ex-
amined the help-seeking behaviour in terms of psycho-
logical processes such as locus of control or type of
symptoms leading to contacts with health professionals
before FEP diagnosis [8, 9]. Platz et al. found that pa-
tients with psychotic symptoms more often contacted
mental health professionals, whereas patients with insidi-
ous and more unspecific features more frequently con-
tacted general practitioners (GPs) [9]. Anderson et al.
also found in their review that in 13 of 21 studies which
examined pathways to care, the first contact for most
patients was with a physician (including all 3 UK stud-
ies). However, the referral source to psychiatric services
for the greatest proportion of patients was emergency
services in 9 of 22 studies which examined such topic
(including 2 of 4 UK studies) [7]. In addition, data from
the UK suggested that individuals referred by a home
treatment team or the emergency service had the lowest
DUP [10]. These probably reflected the lack of identifi-
cation of the symptoms suggestive of FEP in routine care
settings, including primary care services. This is despite
the evidence that contacts with primary care may in-
crease prior to the diagnosis of FEP: a Danish register-
based study suggested an increase in primary care con-
tacts several years prior to the diagnosis of schizophrenia
[11]. A UK study also demonstrated that in general,
higher frequency of GP contact before the onset of
psychosis was associated with shorter DUP [8]. However,
a small study in Switzerland found that patients con-
sulted GPs with insidious features which were not recog-
nised by GPs as being an indication of FEP, hence
causing delays in referral to specialised services, a diag-
nosis made, and treatment initiated [9].
Patterns of consultation and presentation of symptoms
in primary care before the diagnosis of psychosis have
not been fully studied. Identification of these symptoms,
including psychological and physical and substance mis-
use, may help to identify patients earlier, thus helping to
reduce unacceptably long DUP. The objective of this
study was to determine common symptoms and patterns
of symptomatology presented to primary care prior to
diagnosis of FEP. This would help inform the need for
better and more targeted risk management by clinicians
when patients present with symptoms suggestive of FEP.
Methods
Setting
The study was set within the Clinical Practice Research
Datalink (CPRD). CPRD is a pseudo-anonymised data-
base of routinely recorded general practice information
from over 10 million patients registered with over 670
UK primary care practices [12]. Diagnosis of mental and
behavioural disorders recorded in CPRD has been vali-
dated using internal (i.e. manual review of diagnostic al-
gorithm) and external (i.e. questionnaire to GP, record
request to GP, questionnaire and record request to GP,
comparison of rates) methods by 20 studies [13]. It was
also shown that the rates of GP recorded severe mental
illness in UK primary care were broadly comparable to
incidence rates from previous epidemiological studies of
severe mental illness in the UK [14].
Study population
We included patients aged 16–45 years with a first coded
record of a FEP (defined as affective, non-affective, drug-
induced, and pregnancy-related psychoses) between 1 April
2005 (1 year after the introduction of the Quality and Out-
comes Framework (QOF) into UK primary care [15]) and
31 December 2016, who had been registered at a practice
contributing to CPRD for at least 5 years before the re-
corded FEP, and had not received an antipsychotic
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prescription more than 1 year prior to FEP. The rationale
for the antipsychotic prescription criterion was that
treatment may commence before a formal diagnosis
has been entered onto the clinical system, but if
treatment is recorded more than a year before diag-
nosis, this would suggest ongoing active treatment
but inadequate diagnostic recording in primary care.
Patients with a recorded code for Parkinson’s disease
or dementia in the 5 years prior to FEP were ineli-
gible. Patients with a coded record of psychosis in re-
mission during the 5-year period were also excluded.
A control group was identified, matched 4:1 [16] by
year of birth (age), gender, and practice, to the FEP
group. The controls had no recorded consultations
for FEP, psychosis in remission or antipsychotic pre-
scription, and had at least 5 years prior registration
before the index date (which was the diagnosis date
of FEP for their matched case).
Exposure
Recorded symptoms potentially related to FEP in the
5 years prior to the index date in both patients with
FEP and controls were identified and categorised into
eight groups. These symptom groups were determined
through a review of the literature [17–19] and con-
sensus of a consultant in psychiatry (SF) and two
general practitioners with electronic health records
research experience (JE, RH). In general, the final
eight groups were based on the concept of Yung and
McGorry as a foundation [17] and included psycho-
logical, substance-related, and physical symptoms
(Table 1).
Covariates
Covariates thought to be potentially associated with
symptoms/psychosis and recorded in CPRD were year of
the index date, age, gender, geographical region, smok-
ing status, alcohol consumption, body mass index (BMI),
specific co-morbidities, total morbidity burden, and the
frequency of GP consultation.
At the practice level, the geographical region was
recorded by CPRD as 1 of 13 regions in the UK [12].
In this study, these regions were further summarised
into London, South England (South West, South Cen-
tral, South East Coast), Midlands and East England
(East Midlands, West Midlands, East of England),
North England (North East, North West, Yorkshire,
and the Humber), Wales, Scotland, and Northern
Ireland.
Smoking and alcohol information was classified as
ever smoked/drunk alcohol, never, or missing, based
upon the data recorded before the index date. The
BMI value used was the most recent record before
the index date and was grouped into < 18.5 (under-
weight), ≥ 18.5 and < 25 (normal), ≥ 25 and < 30
(overweight), ≥ 30 kg/m2 (obese), or missing. Sensitiv-
ity analyses in patients with and without missing data
on smoking, alcohol drinking, and BMI are briefly
shown in Additional file 1. Findings were similar in
both groups.
Physical comorbidities often co-exist in people with a
mental health problem [20]. Common conditions previ-
ously found to be associated with psychosis were included
in this study. Candidate conditions included diabetes,
ischaemic heart disease, asthma, chronic obstructive pul-
monary disease, inflammatory diseases (rheumatoid arth-
ritis, gout, polymyalgia rheumatic, inflammatory bowel
disease, systemic lupus erythematosus, spondyloarthritis),
hypertension, chronic kidney disease, musculoskeletal pain
(back, foot/ankle, hand/wrist, hip, knee, neck, shoulder),
and injury and major trauma. These conditions were iden-
tified during the 5-year period prior to the index date.
Table 1 Groups of prodromal symptoms in psychosis
Symptom group Individual symptoms† included in each group
Psychological symptom
Mood-related
symptom
Depression, anhedonia, guilt, mood swings, suicidal/self-harm ideation or behaviour
‘Neurotic’ symptom Neuroses, anxiety, irritability and anger, restlessness, worrying thoughts
Behavioural change Deterioration, social withdrawal, impulsivity, reduced self-esteem, aggressive and disruptive behaviour, odd behaviour
Change in volition Apathy (loss of drive), tiredness/fatigue (loss of energy), boredom (loss of interest)
Perceptual problem Hallucinations, delusions, illusions
Cognitive change Disturbance of attention, concentration/preoccupation difficulties, cognitive/memory impairment, thought disorder/
blocking
Substance misuse Opioids, alcohol, cannabis, hypnotic, cocaine, amphetamine, glue, tobacco, hallucinogen, ecstasy, antidepressant, solvent,
other/multiple stimulant, general (codes without specific substance)
Physical symptom Speech abnormality, sleep disturbance, loss of weight, poor appetite, dryness of the mouth, dysphagia, hyperventilation,
muscle tension, epigastric discomfort, palpitations, shortness of breath, excessive wind, decreased libido, menstrual
problem (in females), failure of erection (in males)
†Total number of individual symptoms studied, n = 55
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In addition, prescriptions for drugs recorded under
different British National Formulary (BNF) chapters in
the 5-year period prior to the index date was used as a
surrogate measure of the total morbidity burden, which
has been shown to be as predictive of health outcomes
as more complicated comorbidity measures [21].
The frequency of GP consultation was determined an-
nually over the 5 years prior to the index date.
Codes and identification
In UK primary care, problems, including symptoms and
diagnoses, are generally recorded using the ‘Read’ system
of codes [22]. Diagnosis of FEP and prodrome symptoms
were identified by the use of a Read code list developed
through consensus of clinical researchers (SF, JE, and
RH, see Additional file 2). Identification of co-morbid
conditions used prior established Read code lists within
the research institute.
Antipsychotic medications were defined as medications
under BNF chapter 4.2 (by JE, see Additional file 2).
Statistical analysis
The recorded consultation prevalences of each individual
symptom and symptom group (at least one recorded
symptom from a group) in patients with FEP and
matched controls during the 5-year prior to the index
date were determined. Conditional logistic regression
was used to analyse the associations of individual symp-
toms and symptom groups with FEP in separate models,
adjusted for the other covariates and reported using
odds ratios (ORs) with 95% confidence intervals (CIs).
Cluster-robust variance estimators were used to take
into account clustering by practice.
For patients with FEP, for each symptom group, the
time interval between the first recorded symptom (if
any) and diagnosis was determined. We also identified
the earliest record (if any) of symptoms, regardless of
symptom group, for each patient.
Within patients with FEP, latent class analysis
(LCA) was used to determine common patterns of
symptoms, at the level of the symptom groups, pre-
sented to primary care over the 5-year period before
FEP diagnosis. The LCA clustered patients with FEP
into distinct groups based on their pattern of prior
recorded symptoms across the 8 symptom groups,
with each patient allocated to one cluster [23]. We
used L2 statistics with bootstrap p values, Bayes Infor-
mation Criterion (BIC), and Consistent Akaike’s Infor-
mation Criterion (CAIC) to determine the optimal
model, i.e. the optimal number of clusters. Latent
GOLD (version 4.5) was used to perform the analyses,
using both the estimation-maximisation and Newton-
Raphson algorithms to estimate model parameters.
One thousand different random starting values were
used, each of which included 100 iterations. Bootstrap
p values based on 500 replications were determined
to assess the model fit based on the L2 statistics. The
optimal number of clusters is where the p value be-
comes non-significant at the desired significance level
(5%). For the BIC and CAIC, the optimal model is
the model with the smallest information criterion
values. Patients were allocated to clusters based on
their posterior probabilities of belonging to each clus-
ter. A mean posterior probability ≥ 0.7 for patients al-
located to a cluster was considered acceptable [24].
Based on the optimal model, the identified clusters
were compared at diagnosis on patient characteristics
(psychosis subtype, age, gender, geographical region,
smoking, alcohol drinking, BMI, morbidity burden,
frequency of consultation). The proportions of pa-
tients in each cluster with pre-recorded symptoms 4,
3, 2, and 1 year before diagnosis were identified.
We also mapped each control to the clusters that had
been identified in cases based on their recorded symp-
toms during the 5 years before the index date. Then, in
the case-control setting, a conditional logistic regression
model containing symptom cluster as an independent
variable was used to determine the discriminative ability
of these clusters to predict a FEP diagnosis, assessed
using C-statistic with 95% CIs. A value ≥ 0.75 was con-
sidered to indicate good discrimination.
All analyses were performed using STATA/MP 15 if
not stated elsewhere.
Patient and public involvement
The research findings were discussed with a convenor of
a local support group (‘Hear Our Voices’, North Staf-
fordshire, England) that aims to give a voice to people
with a mental health problem.
Results
Patient characteristics
Three thousand forty-five FEP patients (63% male, me-
dian age 30) and 12,180 age-, gender-, and practice-
matched controls were included in the analysis from 568
general practices. FEP patients were diagnosed most
commonly with non-affective psychosis (67%), followed
by drug-induced (22%), affective (10%), and pregnancy-
related (1%) psychoses (Table 2).
FEP patients were more likely than controls to smoke
and had a lower BMI. Increased morbidity burden was
observed in FEP patients (median of 4 different prescrip-
tions in the previous 5 years versus 3 in the controls).
The median number of GP consultations for FEP pa-
tients was more than double those of controls during
the 5-year period before the index date. FEP patients in-
creased from a median of 6 consultations in the time
period 49–60 months before diagnosis to 17
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Table 2 Participant demographic and clinical characteristics at the index date
FEP patients (n = 3045) Matched participants (n = 12,180) p value
Type of psychosis, n (%)
Non-affective 2036 (66.9) NA
Drug-induced 678 (22.3) NA
Affective 309 (10.2) NA
Pregnancy-related 22 (0.7) NA
Year of the index date, median (IQR) 2010 (2007, 2013) 2010 (2007, 2013) Matched
Age, median (IQR) 30 (23, 39) 30 (23, 39) Matched
Male, n (%) 1914 (62.9) 7656 (62.9) Matched
Geographical region, n (%) Matched
London 271 (8.9) 1084 (8.9)
South England 798 (26.2) 3192 (26.2)
Midlands and East England 599 (19.7) 2396 (19.7)
North England 532 (17.5) 2128 (17.5)
Northern Ireland 168 (5.5) 672 (5.5)
Scotland 356 (11.7) 1424 (11.7)
Wales 321 (10.5) 1284 (10.5)
Smoking, n (%) < 0.0001
Non-smoker 1011 (33.2) 6041 (49.6)
Ever smoker 1764 (57.9) 4031 (33.1)
Unknown 270 (8.9) 2108 (17.3)
Alcohol consumption, n (%) NS
Non-drinker 298 (9.8) 1026 (8.4)
Ever drinker 1742 (57.2) 5907 (48.5)
Unknown 1005 (33.0) 5247 (43.1)
Body mass index, median (IQR) 23.8 (21.0, 27.9) 24.5 (21.6, 28.3) < 0.0001
< 18.5 kg/m2 (underweight), n (%) 150 (4.9) 326 (2.7)
≥ 18.5 kg/m2 and < 25 kg/m2 (normal), n (%) 1085 (35.6) 3578 (29.4)
≥ 25 kg/m2 and < 30 kg/m2 (overweight), n (%) 501 (16.5) 2025 (16.6)
≥ 30 kg/m2 (obese), n (%) 355 (11.7) 1355 (11.1)
Unknown, n (%) 954 (31.3) 4896 (40.2)
Number of different prescriptions in 5 years before
the index date, median (IQR)
4 (3, 6) 3 (1, 5) < 0.0001
Number of GP consultations in 5 years before the
index date, median (IQR)
55 (29, 95) 25 (10, 53) < 0.0001
4–5 years prior to the index date 6 (2, 15)† 3 (1, 9) < 0.0001
3–4 years prior to the index date 7 (2, 16)† 4 (1, 10) < 0.0001
2–3 years prior to the index date 8 (2, 18)† 4 (1, 11) < 0.0001
1–2 years prior to the index date 9 (3, 20)† 4 (1, 11) < 0.0001
0–1 year prior to the index date 17 (8, 30)† 4 (1, 12) < 0.0001
Number of symptom records in 5 years before the index date, median (IQR)‡ 2 (1, 5) 0 (0, 1) < 0.0001
p value obtained from chi-squared or from Mann-Whitney U test as appropriate, and where applicable analysis excluded the ‘unknown’ category (missing data)
FEP first episode psychosis, IQR interquartile range, NA not applicable, NS not significant
†One-way ANOVA trend analysis within patients with FEP, p < 0.0001
‡Total number of coded records based on 55 studied individual symptoms
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consultations in the 12months before diagnosis. The
median number of recorded symptoms was 2 in FEP pa-
tients and 0 in controls over the 5 years (Table 2).
Respiratory comorbidity, musculoskeletal pain, and in-
jury and major trauma were more common in FEP pa-
tients than in controls (Additional file 3).
Prodrome symptoms
Prevalence of recorded individual symptoms over the 5
years is given in Additional file 4.
Prevalence of all symptom groups was higher in FEP
patients than in controls (Table 3). In patients with FEP,
48% were recorded to have at least one mood-related
symptom in the 5 years prior to FEP diagnosis, com-
pared to 11% of controls (adjusted OR 7.6 (95% CI 6.8,
8.6)). ‘Neurotic’ symptoms, behavioural change, change
in volition, and substance misuse were also frequently
recorded (> 10%) in FEP patients. Perceptual problems, a
typical psychotic symptom, were recorded in 5% of FEP
patients but hardly in any controls. Physical symptoms
were recorded in 31% of FEP patients and 16% of con-
trols (adjusted OR 1.8; 95% CI 1.6, 2.0) (Table 3).
Time from the first symptom to diagnosis
Within each symptom group, the median time from first
recorded symptom to diagnosis was around 2 to 2.5
years (range 732–975 days) although shorter for percep-
tual problems (70 days) (Additional file 5, Fig. 1a).
The earliest symptom, regardless of the symptom
group, was recorded around 3 years (median 1065 days)
before diagnosis (Additional file 6).
Common symptom clusters in FEP patients
The LCA analysis using recorded symptom groups prior
to the diagnosis of FEP resulted in the three-cluster model
providing the best fit based on BIC, CAIC, and bootstrap
p values (Additional file 7). FEP patients generally dis-
played high posterior probabilities for their assigned clus-
ters, with mean posterior probabilities ranging from 0.71
to 0.81 across the three clusters (Table 4).
Based on the optimal model, 49% (n = 1487) of FEP
patients were in a cluster characterised by no or minimal
symptoms recorded in primary care in the 5 years before
diagnosis (the ‘no or minimal symptom cluster’, Fig. 1b).
Forty-nine per cent (734/1487) in this cluster had no
prior recorded symptom, and 45% (669/1487) had pre-
sented with symptom(s) from only 1 symptom group,
commonly a mood-related or physical symptom.
The second cluster contained 40% (n = 1220) of FEP
patients, and these had consulted with symptoms from
at least 1 symptom group (median number 2), and pa-
tients in the cluster mainly had ‘neurotic’ (74%) or
mood-related (67%) symptoms (the ‘affective symptom
cluster’, Fig. 1c). Forty-four per cent (541/1220) of pa-
tients in this cluster had consulted for both mood-
related and ‘neurotic’ symptoms. All patients with a
mood-related symptom in this cluster also presented
with at least one other symptom from another symptom
group.
Cluster 3 contained 11% (n = 338) of FEP patients, and
they consulted across multiple symptom groups (median
number 4) with high probability of consulting in particu-
lar for physical (90%), mood-related (90%), ‘neurotic’
(69%), behavioural (65%), and volition change (62%)
symptoms (the ‘multiple symptom cluster’, Fig. 1d). All
patients in cluster 3 consulted for symptoms in at least
three symptom groups.
Relative to the affective symptom cluster, the no or min-
imal symptom cluster had a higher proportion of patients
with non-affective psychosis, while the multiple symptom
Table 3 Five-year prevalence of symptom groups in patients prior to psychosis and matched participants
Symptom group FEP patients (n = 3045) Matched participants (n = 12,180) Crude odds
ratio (95% CI)‡
Adjusted odds
ratio‡* (95% CI)n† 5-year prevalence (%) n† 5-year prevalence (%)
Psychological symptom
Mood-related symptom 1473 48.4 1275 10.5 10.1 (9.12, 11.3) 7.60 (6.75, 8.56)
‘Neurotic’ symptom 1133 37.2 1106 9.1 6.54 (5.89, 7.27) 4.87 (4.35, 5.47)
Behavioural change 490 16.1 657 5.4 3.53 (3.08, 4.05) 2.67 (2.30, 3.09)
Change in volition 394 12.9 923 7.6 1.88 (1.64, 2.16) 1.33 (1.14, 1.55)
Perceptual problem 162 5.3 5 0.04 130 (53.7, 313) 112 (44.4, 283)
Cognitive change 38 1.3 30 0.3 5.41 (3.35, 8.75) 3.80 (2.04, 7.09)
Substance misuse 338 11.1 134 1.1 13.0 (10.4, 16.4) 8.09 (6.36, 10.3)
Physical symptom 939 30.8 1926 15.8 2.70 (2.43, 2.99) 1.80 (1.61, 2.02)
FEP first episode psychosis, CI confidence interval
†Number of individuals with recorded symptom in the 5-year period before the index date
‡Conditional logistic regression analyses with cluster-robust variance estimator
*Adjusted for smoking, alcohol consumption, BMI morbidity burden, and specific co-morbid conditions (including respiratory condition, musculoskeletal pain, and
injury and major trauma), in addition to matched year of birth (age), gender, and practice
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cluster included a higher proportion of patients with affective
and drug-induced psychosis (Table 5). The no or minimal
symptom cluster patients were the youngest (median age 29
years) and had the highest percentage being male (72%). The
multiple symptom cluster patients were the oldest (median
age 33 years) and had the lowest percentage being male
(36%). This cluster also had the highest rates of recorded
obesity, alcohol drinking, morbidity burden, and frequency of
GP consultations (Table 5). Patients in the multiple symptom
cluster had a median of 4 years (median 1548 days) from
earliest symptom to diagnosis, with mood-related (31%) and
physical (29%) as the most common earliest symptoms
(Additional file 6).
Symptom clusters emerging over time before FEP
diagnosis
Nine per cent of FEP patients could already be classified
into the affective symptom cluster at 4 years before diag-
nosis and 28% at 1 year before diagnosis. One per cent
of FEP patients could be classified in the multiple symp-
tom cluster 4 years before diagnosis, rising to 7% at 1
year before diagnosis (Fig. 2).
Fig. 1 Cumulative proportion of patients having a prodrome symptom recorded in primary care from 5 years before until the time of FEP
diagnosis. FEP, first episode psychosis; NMSC, no or minimal symptom cluster; ASC, affective symptom cluster; MSC, multiple symptom cluster
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Discriminative ability of symptom clusters on FEP
diagnosis
The majority of controls (87%, n = 10,554) were mapped
to the no or minimal symptom cluster, followed by the
affective (11%, n = 1314) and multiple (3%, n = 312)
symptom clusters. The affective and multiple symptom
clusters (versus the no or minimal symptom cluster)
demonstrated a good discriminative ability for FEP pre-
dictive classification (C-statistic 0.766 (95% CI 0.757,
0.775); sensitivity = 51.2%; specificity = 86.7%).
Discussion
This large study utilising a national primary care data-
base has shown three distinct patterns of symptom pres-
entation prior to FEP diagnosis, with more than one in
ten patients presenting with multiple different symptoms
in the 5 years prior to diagnosis. Many patients diag-
nosed with FEP have a long history of relevant symptom
presentation to primary care.
Major findings
This study has shown that symptoms are often presented
several years prior to the diagnosis of FEP. The median
time interval between the first recorded potential pro-
dromal symptom and a coded FEP diagnosis was around
two or more years. This is longer than the reported aver-
age DUP [2–4], although our study in primary care can-
not assess whether the recorded symptoms are part of
the FEP prodrome.
In particular, there are a group of patients (11% of all
those diagnosed with FEP) who have presented with
multiple symptoms in the previous 5 years before diag-
nosis. This group has high rates of consultations and
present with a range of morbidity before the diagnosis of
FEP. This group may represent patients who could be
recognised sooner as the median time of the earliest re-
corded symptom is about 4 years before FEP. Approxi-
mately two thirds of this cluster were female, and it may
be that GPs are less likely to recognise potential FEP in
females. The second group of patients (40%) mainly
presented with affective symptoms (such as mood-
related and neurotic symptoms) prior to diagnosis. The
third group of patients (49%) had no or minimal symp-
toms recorded in primary care, suggesting either an in-
sidious onset disease or limited prior use of primary
care. The group tended to be of younger age at diagno-
sis, male, with lower BMI, morbidity burden, and lower
rate of GP consultations.
We found that many patients who later go on to re-
ceive the diagnosis of FEP consulted their GP with in-
creasing regularity over the 5 years before diagnosis and
particularly in the 12 months before diagnosis (more
than quadruple the frequency of consultation than our
control group). These findings confirm this population
in general is actively help-seeking, but those prodromal
symptom presentations may be difficult for GPs to elicit
and distinguish from less severe states and disorders.
However, there remains a quarter of patients with no
record of coded symptoms in the primary care database,
who may not be actively seeking related help from their
GP in the 5 years before FEP diagnosis.
High rates of recorded physical co-morbidities such as
respiratory conditions might be expected in a population
known to smoke heavily [25]. The high rates of recorded
physical symptoms, and with comorbid musculoskeletal
pain, are a novel finding and may relate to the increased
levels of somatic complaints prior to FEP diagnosis.
Somatic complaints have previously been recognised to
be a frequent manifestation of psychological distress in
common mental health disorders such as depression and
anxiety [26].
Mood-related, ‘neurotic’, and physical symptoms were
among the most frequently recorded. Common psycho-
logical symptoms that characterise the at risk mental
state or the ultrahigh risk stage before the actual diagno-
sis of psychosis include social isolation or withdrawal,
impairment in personal hygiene and grooming, blunted
or inappropriate affect, odd beliefs or magical thinking,
and unusual perceptual experiences [27]. These were not
commonly recorded symptoms in primary care, but once
coded, heralded a shorter period to diagnosis. GPs may
be reluctant to enquire about psychotic symptoms. It is
possible that the low prevalence of these symptoms in
the GP records is due to inadequate awareness that these
clinical manifestations may herald the onset of
psychosis.
Substance misuse was commonly recorded in FEP
patients. This underlines the importance of GPs recog-
nising that FEP is commonly preceded or accompan-
ied by co-morbid substance misuse. It is therefore
important not to misattribute relevant symptom pre-
sentations purely to substance misuse without careful
exploration of the possibility of an emerging psychotic
disorder [28].
Table 4 Cluster classification: posterior probability of
membership of clusters
Assigned cluster,
n (%)
Mean posterior probability for each cluster
NMSC ASC MSC
NMSC, n = 1487
(48.8)
0.809 0.174 0.018
ASC, n = 1220
(40.1)
0.128 0.713 0.159
MSC, n = 338
(11.1)
0.022 0.236 0.743
NMSC no or minimal symptom cluster, ASC affective symptom cluster, MSC
multiple symptom cluster
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Table 5 Characteristics at diagnosis of FEP patients by cluster
Symptom clusters p value†
NMSC patients
(n = 1487)
ASC patients
(n = 1220)
MSC patients
(n = 338)
Type of psychosis, n (%)‡ < 0.0001
Non-affective 1023 (68.8) 819 (67.1) 194 (57.4)
Drug-induced 305 (20.5) 277 (22.7) 96 (28.4)
Affective 146 (9.8) 117 (9.6) 46 (13.6)
Male, n (%) 1064 (71.6) 727 (59.6) 123 (36.4) < 0.0001
Age, median (IQR) 29 (21, 38) 31 (24, 38) 33 (25, 41) < 0.0001
Year of the index date, median (IQR) 2010 (2007, 2013) 2010 (2007, 2013) 2010 (2007, 2012) NS
Geographical region, n (%) < 0.0001
London 158 (10.6) 92 (7.5) 21 (6.2)
South England 406 (27.3) 300 (24.6) 92 (27.2)
Midlands and East England 274 (18.4) 249 (20.4) 76 (22.5)
North England 243 (16.3) 236 (19.3) 53 (15.7)
Northern Ireland 53 (3.6) 92 (7.5) 23 (6.8)
Scotland 189 (12.7) 125 (10.3) 42 (12.4)
Wales 164 (11.0) 126 (10.3) 31 (9.2)
Smoking, n (%) 0.022
Non-smoker 495 (33.3) 387 (31.7) 129 (38.2)
Ever smoker 802 (53.9) 768 (63.0) 194 (57.4)
Unknown 190 (12.8) 65 (5.3) 15 (4.4)
Alcohol consumption, n (%) 0.005
Non-drinker 155 (10.4) 112 (9.2) 31 (9.2)
Ever drinker 730 (49.1) 777 (63.7) 235 (69.5)
Unknown 602 (40.5) 331 (27.1) 72 (21.3)
Body mass index, median (IQR) 23.4 (20.9, 27.1) 23.8 (21.0, 28.1) 25.0 (21.3, 30.2) < 0.0001
< 18.5 kg/m2 (underweight), n (%) 65 (4.4) 61 (5.0) 24 (7.1)
≥ 18.5 kg/m2 and < 25 kg/m2 (normal),
n (%)
502 (33.8) 460 (37.7) 123 (36.4)
≥ 25 kg/m2 and < 30 kg/m2 (overweight),
n (%)
215 (14.5) 215 (17.6) 71 (21.0)
≥ 30 kg/m2 (obese), n (%) 125 (8.4) 154 (12.6) 76 (22.5)
Unknown, n (%) 580 (39.0) 330 (27.1) 44 (13.0)
Number of different prescriptions in 5 years
before diagnosis, median (IQR)
3 (2, 5) 5 (3, 7) 7 (5, 8) < 0.0001
Number of GP consultations in 5 years before
diagnosis, median (IQR)
36 (19, 65) 66 (42, 103) 119 (79, 171) < 0.0001
4–5 years prior to diagnosis 4 (1, 10) 8 (3, 17) 15 (8, 27) < 0.0001
3–4 years prior to diagnosis 4 (1, 11) 9 (3, 18) 18 (9, 33) < 0.0001
2–3 years prior to diagnosis 5 (1, 11) 10 (4, 20) 21 (11, 33) < 0.0001
1–2 years prior to diagnosis 6 (2, 13) 13 (5, 22) 21 (12, 40) < 0.0001
0–1 year prior to diagnosis 11 (5, 21) 21 (11, 33) 32 (19, 52) < 0.0001
FEP first episode psychosis, NMSC no or minimal symptom cluster, ASC affective symptom cluster, MSC multiple symptom cluster, NS not significant
†Obtained from chi-squared or univariable multinomial logistic regression analysis as appropriate, and where applicable analysis excluded the unknown category
(missing data)
‡Data were not reported for pregnancy-related psychosis due to CPRD reporting policy that no cell should contain fewer than five events
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The affective and multiple symptom cluster patterns
were rare in our control group. Our discriminative
ability analysis for FEP classification has shown that
these two patterns of symptom presentation are
suggestive (C-statistic 0.766) for a potential FEP.
Importantly, many patients already had these symptom
patterns several years before a FEP diagnosis (one
third 1 year before diagnosis, a quarter at 2 years
before diagnosis, a fifth at 3 years before diagnosis),
giving an opportunity for earlier awareness, referral,
and diagnosis.
Comparison with the existing literature
The literature on the patterns of symptoms in the poten-
tially long prodromal period before the onset of psychosis
is limited. Most studies on the identification of symptom
patterns focus on help-seeking ultrahigh-risk populations
in specialised mental health service settings [29–31] or ex-
amined individual symptoms prior to the diagnosis [32].
We are not aware of any other previous study that has in-
vestigated the pattern of symptoms presentation for indi-
viduals who are help-seeking in primary care over a long
observational period prior to diagnosis, although a survey
investigation has modelled subtypes of psychosis-like ex-
periences in the general population using similar latent-
class analytical approach [33].
An American study described patterns of health
care use before FEP in adolescents and young adults.
Although it included previous diagnoses of depressive,
anxiety, attention deficit, bipolar, and substance use
disorders as an indication of mental health problem,
the pattern of symptoms and their relationship with
the diagnosis of FEP was not studied [34]. Sullivan
et al. examined 13 individual symptoms recorded in
primary care to assess the positive predictive value of
single or paired symptoms for a diagnosis of psych-
osis between 2000 and 2009 [32]. The majority of the
symptoms (n = 12) were linked to later psychosis diag-
nosis, with suicidal behaviour as the most strongly as-
sociated common predictor. We also found a strong
association with suicidal behaviour and self-harm but
have extended Sullivan’s study by examining 55 indi-
vidual symptoms and determining common patterns
of presentation prior to diagnosis.
Fig. 2 Proportion of patients allocated to the three clusters based on pre-recorded symptoms at different time points before FEP diagnosis. FEP,
first episode psychosis; NMSC, no or minimal symptom cluster; ASC, affective symptom cluster; MSC, multiple symptom cluster. Symptom clusters
are identified based on the data from 5 years before diagnosis up to each time point
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Strengths and limitations
The increasing availability and quality of routinely recorded
longitudinal primary care electronic health records offer the
opportunity to investigate the patterns of symptoms
recorded before a FEP diagnosis in a larger and more
generalizable setting. We restricted the analysis to the
period following the introduction of the QOF in the UK
which increased the quality of recording in primary care.
However, the recording of diagnosis of FEP made in
secondary care may be delayed in entry into primary care
records, and patients with a diagnosis of psychosis recorded
only in secondary care would not be included in our
analysis. We excluded those with a long history of
antipsychotic medication (more than 1 year) which should
mean patients with FEP included in our analysis had a
recent diagnosis, and this study used a UK national primary
care database (CPRD) with previous validation of the
accuracy and completion of diagnosis recording of mental
and behavioural disorders [13]. The median age (30 years
old) at FEP diagnosis in our study was comparable with
that (31) at a treated incidence of psychotic disorder in a
recent large European (including England) multinational
study [35]. A 5-year observational period was considered
long enough to identify insidious symptoms related to
FEP, although it is possible that relevant symptoms will
present more than 5 years before FEP diagnosis. Not all
symptoms identified will necessarily have reflected a
prodromal phase of FEP in all patients. A further limitation
to this study is the lack of primary care recording of
concerns raised by families, potentially an important factor
in alerting a GP to the presence of a more serious mental
disorder. We included over 50 individual symptoms identi-
fied through a review of the literature [17–19], but other
symptoms may be missed. We summarised the psycho-
logical symptoms into 6 groups largely based on the work
of Yung and McGorry [17], but there may be other
approaches to grouping the symptoms. We included 15
physical symptoms together as a single group, but we are
aware that these somatic complaints are diverse in nature.
It is possible that symptoms may not be coded but are
recorded in the consultation free text that GPs use along-
side the Read codes. However, it is likely that those with a
coded symptom are those with more troublesome or
noticeable symptoms. No attempt was made to grade the
degree of each symptom. There was some missing data on
covariates including smoking, alcohol drinking, and BMI, as
is usual in research using primary care health record data-
bases and particularly in younger populations. The rapid
development of the early intervention in psychosis services
in England between 2000 and 2010 may have caused
geographical variation in the responsiveness of GPs to
psychosis presentations where they had direct access to
specialist FEP assessment [36]. The generalisability of the
findings from this study has yet to be assessed.
Impact and implications
The criteria that use psychiatric and cognitive symptoms
for recognition of prodromal stage or at risk mental state
for psychosis do not work well outside defined clinical
population samples and not within the general population
seeking help in primary care [37]. This study highlights the
opportunities in primary care for identifying patients who
may be experiencing a prodromal state of psychosis rather
than awaiting the emergence of major psychotic symptoms
or acute psychosis. Our study has highlighted there is a sig-
nificant minority (often female) who may be waiting several
years for a diagnosis and are actively seeking help in pri-
mary care. This is a group whose characteristics GPs should
be particularly be aware of to allow the opportunity for
earlier recognition, referral, and diagnosis. The three clus-
ters suggested in the present study represent the first at-
tempt to link common prodromal presentations in primary
care to the identification of subsequent FEP. The curricu-
lum and training programmes for GPs need a greater focus
on early detection of symptoms suggestive of psychosis and
its prodrome. It may be possible to link these symptoms
and clusters with existing criteria and other markers (such
as increasing frequency of GP attendance, suicidality, social
withdrawal, and a history of severe mental illness) to iden-
tify the people at high risk of psychosis at the earliest pos-
sible stage, as a risk prediction model, hence contributing
to more effective treatment strategies to improve outcomes.
Patient and public involvement
The findings were discussed with a convenor of a local
support group (‘Hear Our Voices’, North Staffordshire,
England) that aims to give a voice to people with a mental
health problem. He suggested that the findings made sense
and emphasised the reluctance of men, who might use
alcohol and cigarettes as a coping strategy, to access care.
He suggested that the association of lower BMI with FEP
patients may reflect a lack of self-care despite possible
metabolic abnormalities, and the observation of increased
injury and major trauma in FEP patients may be due to
excess risky behaviours. He was concerned that suicidality
was recorded in about 6% of people who were later
diagnosed with FEP, about 14 times commoner than in
controls. He emphasised the importance of this work in
providing clues for GPs to increase their awareness of the
possibility of an emerging psychosis.
Conclusions
Our study identified three distinctive patterns of prodromal
symptom presentations in patients seeking help in primary
care and subsequently diagnosed with FEP. Awareness of
these symptom clusters may help GPs to identify patients
who are experiencing a prodromal state of psychosis,
thereby facilitating more timely access to specialist assess-
ment and treatment and hence better long-term outcomes.
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